| Literature DB >> 26603296 |
Alex J Bott1, I-Chen Peng2, Yongjun Fan1, Brandon Faubert3, Lu Zhao4, Jinyu Li5, Sarah Neidler6, Yu Sun1, Nadia Jaber1, Dawid Krokowski7, Wenyun Lu8, Ji-An Pan1, Scott Powers5, Joshua Rabinowitz8, Maria Hatzoglou7, Daniel J Murphy6, Russell Jones3, Song Wu4, Geoffrey Girnun5, Wei-Xing Zong9.
Abstract
c-Myc is known to promote glutamine usage by upregulating glutaminase (GLS), which converts glutamine to glutamate that is catabolized in the TCA cycle. Here we report that in a number of human and murine cells and cancers, Myc induces elevated expression of glutamate-ammonia ligase (GLUL), also termed glutamine synthetase (GS), which catalyzes the de novo synthesis of glutamine from glutamate and ammonia. This is through upregulation of a Myc transcriptional target thymine DNA glycosylase (TDG), which promotes active demethylation of the GS promoter and its increased expression. Elevated expression of GS promotes cell survival under glutamine limitation, while silencing of GS decreases cell proliferation and xenograft tumor growth. Upon GS overexpression, increased glutamine enhances nucleotide synthesis and amino acid transport. These results demonstrate an unexpected role of Myc in inducing glutamine synthesis and suggest a molecular connection between DNA demethylation and glutamine metabolism in Myc-driven cancers.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26603296 PMCID: PMC4670565 DOI: 10.1016/j.cmet.2015.09.025
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287